Skip to content

Comparative study between DADRUVIDRAVAN MALHAR-TAILA on treating skin diseases called DADRU (Ring worm)

A Comparative Pharmaceutico-clinical study on DADRUVIDRAVAN MALHAR-TAILA with their effect on DADRU w.s.r to Tinea - Nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/085813
Enrollment
60
Registered
2025-04-28
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B354- Tinea corporis

Interventions

None listed

Sponsors

Dr Sudhanya V S
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Selection will be based on the signs and symptoms explained in both Ayurvedic and modern contexts.

Exclusion criteria

Exclusion criteria: Age group below 10 and above 70 years. Pregnant and lactating women Patients of dadru having a secondary infections. Patients having any other systemic illness.

Design outcomes

Primary

MeasureTime frame
To evaluate the effect of Dadruvidravan Malhar - Taila on Dadru w.s.r to TineaTimepoint: Patients will be evaluated after every 15 days out of 90 days trail

Secondary

MeasureTime frame
To study the preparation of Safe, effective, and quality drug and standardizationTimepoint: 90 days

Countries

India

Contacts

Public ContactDr Prof Prabhat Kumar Dwivedi

Government Ayurvedic College And Hospital

drprabhatkd@gmail.com9431172175

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026